Browsing Wolfson Institute of Preventive Medicine by Author "Baehner, FL"
Now showing items 1-5 of 5
-
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Sestak, I; Buus, R; Cuzick, J; Dubsky, P; Kronenwett, R; Denkert, C; Ferree, S; Sgroi, D; Schnabel, C; Baehner, FL (2018-04-01)Importance: Multiple molecular signatures are available for managing estrogen receptor (ER)-positive breast cancer but with little direct comparative information to guide the patient's choice. Objective: To conduct a ... -
Correlation between and molecular drivers of oncotype DX, prosigna, EndoPredict and breast cancer index: A TransATAC study
Buus, R; Sestak, I; Dowsett, M; Kronenwett, R; Ferree, S; Schnabel, C; Baehner, FL; Cuzick, J (2020-02) -
Correlations between and molecular drivers of oncotype DX, prosigna, EndoPredict and breast cancer index: a TransATAC study
Buus, R; Sestak, I; Dowsett, M; Kronenwett, R; Ferree, S; Schnabel, CA; Baehner, FL; Cuzick, J (2020-04) -
Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.
Buus, R; Sestak, I; Kronenwett, R; Ferree, S; Schnabel, CA; Baehner, FL; Mallon, EA; Cuzick, J; Dowsett, M (American Society of Clinical Oncology, 2020-10-27)PURPOSE: The Oncotype DX Recurrence Score (RS), Prosigna Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) are used clinically for estimating risk of ... -
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors
Sestak, I; Dowsett, M; Ferree, S; Baehner, FL; Cuzick, J (2016-08)